SHANGHAI NO.1 PHARMACY financial statements, including revenue, expenses, profit, and loss
The total revenue of 600833 for the last quarter is 479.27 M CNY, and it's 9.80% higher compared to the previous quarter. The net income of Q4 23 is 31.77 M CNY.